Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose lidocaine gel for local anesthesia during transurethral DJ ureteral stent procedures
2026-526288-40-00Phase 3Authorised
- Sponsor
- FARCO-PHARMA
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine in Ureteral obstruction (UO) (2 arms), sponsored by FARCO-PHARMA. Primary endpoint: Intraoperative pain intensity. Planned start Oct 2026; status: authorised.
02
Drugs
lidocaine
03
Conditions
Ureteral obstruction (UO)
Beyond the preview
Go deeper on 2026-526288-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526288-40-00.